Skip to main content
SpringerLink
Log in

Cirrhosis and End-Stage Liver Disease

  • Chapter
  • First Online:
Surgical Critical Care Therapy

  • 1997 Accesses

Abstract

An experienced surgeon always approaches cirrhosis or end-stage liver disease with some trepidation. In the chapter that follows, we review the management of system and specific scenarios encountered while caring for critically ill patients with severe liver disease before and after surgery. The chapter provides a typical intensive care unit system-based approach with more detailed discussions of the management of specific clinical challenges as relevant.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Child CG, Turcott JGT. Surgery and portal hypertension. In: Child CG, editor. Liver and portal hypertension. Philadelphia: Saunders; 1964.

    Google Scholar 

  2. Befeler AS, Palmer DE, Hoffman M, Longo W, Solomon H, Di Biscegli AM. The safety of intra-abdominal surgery in patients with cirrhosis: model for end-stage liver disease score is superior to Child-Turcotte-Pugh classification in predicting outcome. Arch Surg. 2005;140:650–4.

    Article  Google Scholar 

  3. Inaba K, Barmparas G, Resnick S, Browder T, Chan LS, Lam L, et al. The model for end-stage liver disease score. Arch Surg. 2011;146:1074.

    Article  Google Scholar 

  4. Reverter E, Tandon P, Augustin S, Turon F, Casu S, Bastiampillai R, et al. A MELD-based model to determine risk of mortality among patients with acute variceal bleeding. Gastroenterology. 2014;146:412.

    Article  Google Scholar 

  5. Northup PG, Wanamaker RC, Lee VD, Adams RB, Berg CL. Model for end-stage liver disease (MELD) predicts nontransplant surgical mortality in patients with cirrhosis. Ann Surg. 2005;242:244.

    Article  Google Scholar 

  6. Annamalai A, Harada MY, Chen M, Tran T, Ko A, Ley E, et al. Predictors of mortality in the critically ill cirrhotic patient: is the model for end-stage liver disease enough? J Am Coll Surg. 2016;16:1636–42.

    Google Scholar 

  7. Dalal A, Lang JD. Anesthesthetic considerations for patients with liver disease. In: Abdeldayem H, editor. Hepatic surgery. Ruheja: InTech; 2013.

    Google Scholar 

  8. Guo G, XZ W, LJ S, Yang CQ. Clinical features of ischemic hepatitis caused by shock with four different types: a retrospective study of 328 cases. Int J Clin Exp Med. 2016;8:16670–5.

    Google Scholar 

  9. Fouad YM, Yehia R. Hepato-cardiac disorders. World J Hepatol. 2014;27:41–54.

    Article  Google Scholar 

  10. Poelzl G, Auer J. Cardiohepatic syndrome. Curr Heart Fail Rep. 2014;12:68.

    Article  Google Scholar 

  11. Tatum JM, Quinn AM, Genyk YS, Sher LS, Matsuoka LK, Hackman A, et al. Cardiac surgery at the time of simultaneous liver-kidney transplantation. J Curr Surg. 2016;6:37–40. https://doi.org/10.14740/jcs300w

    Article  Google Scholar 

  12. Bolognesi M. Splanchnic vasodilation and hyperdynamic circulatory syndrome in cirrhosis. World J Gastroenterol. 2014;20:2555.

    Article  Google Scholar 

  13. Ge PS, Runyon BA. Treatment of patients with cirrhosis. N Engl J Med. 2016;375:767.

    Article  CAS  Google Scholar 

  14. Chen A, Massoni J, Jung D, Crippin J. Indwelling tunneled catheter for the management of hepatic hydrothorax. A pilot study. Ann Thorac Surg. 2016;13:435–8.

    Google Scholar 

  15. Mirrakhimov AE, Ayach T, Gray A. Indwelling tunneled pleural catheter for the management of hepatic hydrothorax: a word of caution. Ann Thorac Surg. 2016;13:1432.

    Google Scholar 

  16. Jung Y. Surgical treatment of hepatic hydrothorax: a “four-step approach”. Ann Thorac Surg. 2016;101:1195–7.

    Article  Google Scholar 

  17. Bartoletti M, Giannella M, Caraceni P, Domenicali M, Ambretti S, Tedeschi S, et al. Epidemiology and outcomes of bloodstream infection in patients with cirrhosis. J Hepatol. 2014;61:51.

    Article  Google Scholar 

  18. O’Brien AJ, Fullerton JN, Massey KA, Auld G, Sewell G, James S, et al. Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2. Nat Med. 2014;20:518.

    Article  Google Scholar 

  19. Hassan EA, El-Rehim ASA, Hassany SM, Ahmed AO, Elsherbiny NM, Mohammed MH. Fungal infection in patients with end-stage liver disease: low frequency or low index of suspicion. Int J Infect Dis. 2014;23:69.

    Article  Google Scholar 

  20. Møller S. Extrahepatic complications to cirrhosis and portal hypertension: haemodynamic and homeostatic aspects. World J Gastroenterol. 2014;20:15499.

    Article  Google Scholar 

  21. Cosarderelioglu C, Cosar AM, Gurakar M, Dagher NN, Gurakar A. Hepatopulmonary syndrome and liver transplantation: a recent review of the literature. J Clin Transl Hepatol. 2016;4:47–53.

    Article  Google Scholar 

  22. Levesque E, Saliba F, Ichaï P, Samuel D. Outcome of patients with cirrhosis requiring mechanical ventilation in ICU. J Hepatol. 2014;60:570.

    Article  CAS  Google Scholar 

  23. Lee KC, Chiang AA. THe outcome of terminal liver cirrhosis patients requiring mechanical ventilation. Med J Free China Ed. 1997;1997:88–94.

    Google Scholar 

  24. Goldfarb G, Nouel O, Poynard T, Reuff B. Efficiency of respiritory assistance in cirrhotic patients with liver failure. Intensive Care Med. 1983;9:271–3.

    Article  CAS  Google Scholar 

  25. Chihara Y. Use of noninvasive ventilation for pediatric patients after liver transplantation: a decrease in the need for reintubation. Liver Transpl. 18:1217–5.

    Google Scholar 

  26. Karcz M, Schwaiberger D, Lachmann B, Papadakos PJ. Acute respiratory failure complicating advanced liver disease. Semin Respir Crit Care Med. 2012;33:96–110.

    Article  Google Scholar 

  27. Plauth M, Cabré E, Riggio O, Assis-Camilo M, Pirlich M, Kondrup J, et al. ESPEN guidelines on enteral nutrition: liver disease. Clin Nutr. 2006;25:285.

    Article  CAS  Google Scholar 

  28. Galloway AC, Schwartz CF, Ribakove GH, Crooke GA, Gogoladze G, Ursomanno P, et al. A decade of minimally invasive mitral repair: long-term outcomes. Ann Thorac Surg. 2009;88:1180.

    Article  Google Scholar 

  29. Kalaitzakis E. Gastrointestinal dysfunction in liver cirrhosis. World J Gastroenterol. 2014;20:14686.

    Article  CAS  Google Scholar 

  30. Koretz RL, Avenell A, Lipman TO. Nutritional support for liver disease. Cochrane Database Syst Rev. 2012;(5):CD008344.

    Google Scholar 

  31. Benjamin J, Singla V, Arora I, Sood S, Joshi YK. Intestinal permeability and complications in liver cirrhosis: a prospective cohort study. Hepatol Res. 2012;43:200.

    Article  Google Scholar 

  32. Jakubczyk M, Różowicz A, Spychalska K, Nakonowska B, Kupczyk K, Kusza K. Analysis of occurrence of bacteraemia with pathogens from gastrointestinal tract in patients fed parenterally and enterally in the intensive care unit. Gastroenterol Rev. 2016;2:127.

    Article  Google Scholar 

  33. Kim JJ, Tsukamoto MM, Mathur AK, Ghomri YM, Hou LA, Sheibani S, et al. Delayed paracentesis is associated with increased in-hospital mortality in patients with spontaneous bacterial peritonitis. Am J Gastroenterol. 2014;109:1436.

    Article  CAS  Google Scholar 

  34. Runyon BA. Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012. Hepatology. 2013;57:1651.

    Article  Google Scholar 

  35. Nasr G, Hassan A, Ahmed S, Serwah A. Predictors of large volume paracentesis induced circulatory dysfunction in patients with massive hepatic ascites. J Cardiovasc Dis Res. 2010;1:136.

    Article  CAS  Google Scholar 

  36. Kathpalia P, Bhatia A, Robertazzi S, Ahn J, Cohen SM, Sontag S, et al. Indwelling peritoneal catheters in patients with cirrhosis and refractory ascites. Intern Med J. 2015;45:1026.

    Article  CAS  Google Scholar 

  37. Belghiti J, Durand F. Abdominal wall hernia in the setting of cirrhosis. Semin Liver Dis. 1997;17:219–26.

    Article  CAS  Google Scholar 

  38. Carbonell AM, Wolfe LG, DeMaria EJ. Poor outcomes in cirrhosis-associated hernia repair: a nationwide cohort study of 32,033 patients. Hernia. 2005;9:353.

    Article  Google Scholar 

  39. Coelho JC, Claus CM, Campos AC, Costa MA, Blum C. Umbilical hernia in patients with liver cirrhosis: a surgical challenge. World J Gastrointest Surg. 2016;8:476.

    Article  Google Scholar 

  40. Curro G. Percutaneous gall bladder aspiration as an alternative to laparoscopic cholecystectomy in Child-Pugh C cirrhotic patients with acute cholecystitis. Gut. 2006;55:898.

    Article  CAS  Google Scholar 

  41. Delis S, Bakoyiannis A, Madariaga J, Bramis J, Tassopoulos N, Dervenis C. Laparoscopic cholecystectomy in cirrhotic patients: the value of MELD score and Child–Pugh classification in predicting outcome. Surg Endosc. 2009;24:407.

    Article  Google Scholar 

  42. Hall J, Singh G, Hood D, Mateo R, Weaver F, Selby R, et al. Management of an abdominal aortic aneurysm in a patient with end-stage liver disease. Am J Transplant. 2004;4:666.

    Article  Google Scholar 

  43. Sabbagh C, Chatelain D, Nguyen-Khac E, Rebibo L, Joly J-P, Regimbeau J-M. Management of colorectal cancer in patients with cirrhosis: a retrospective, case-matched study of short- and long-term outcomes. Dig Liver Dis. 2016;48:429.

    Article  Google Scholar 

  44. D'Amico G. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology. 2003;38:599.

    Article  Google Scholar 

  45. Garcia-Tsao G, Sanyal AJ, Grace ND, Carey WD. Prevention and management of gastroesophageal varices and variceal hemorrhage in Cirrhosis. Am J Gastroenterol. 2007;102:2086.

    Article  Google Scholar 

  46. de Franchis R. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 2010;53:762.

    Article  Google Scholar 

  47. O’Leary JG, Reddy KR, Wong F, Kamath PS, Patton HM, Biggins SW, et al. Long-term use of antibiotics and proton pump inhibitors predict development of infections in patients with cirrhosis. Clin Gastroenterol Hepatol. 2015;13:753.

    Article  Google Scholar 

  48. McCarty TR, Njei B. Self-expanding metal stents for acute refractory esophageal variceal bleeding: a systematic review and meta-analysis. Dig Endosc. 2016;28:539.

    Article  Google Scholar 

  49. Ginès P, Schrier RW. Renal failure in cirrhosis. N Engl J Med. 2009;361:1279.

    Article  Google Scholar 

  50. Restuccia T, Ortega R, Guevara M, Ginès P, Alessandria C, Ozdogan O, et al. Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. A case-control study. J Hepatol. 2004;40:140.

    Article  Google Scholar 

  51. Schepke M, Appenrodt B, Heller J, Zielinski J, Sauerbruch T. Prognostic factors for patients with cirrhosis and kidney dysfunction in the era of MELD: results of a prospective study. Liver Int. 2006;26:834.

    Article  Google Scholar 

  52. Alessandria C, Ozdogan O, Guevara M, Restuccia T, Jiménez W, Arroyo V, et al. MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation. Hepatology. 2005;41:1282.

    Article  Google Scholar 

  53. Lloyd-Donald P, Vasudevan A, Angus P, Gow P, Mårtensson J, Glassford N, et al. Coagulation in acutely ill patients with severe chronic liver disease: insights from thromboelastography. J Crit Care. 2017;38:215.

    Article  Google Scholar 

  54. Tripodi A, Anstee QM, Sogaard KK, Primignani M, Valla DC. Hypercoagulability in cirrhosis: causes and consequences. J Thromb Haemost. 2011;9:1713.

    Article  CAS  Google Scholar 

  55. Rodríguez-Castro KI. Spontaneous bleeding or thrombosis in cirrhosis: what should be feared the most? World J Hepatol. 2015;7:1818.

    Article  Google Scholar 

  56. Raja K, Jacob M, Asthana S. Portal vein thrombosis in cirrhosis. J Clin Exp Hepatol. 2014;4:320.

    Article  Google Scholar 

  57. Aggarwal A. Deep vein thrombosis and pulmonary embolism in cirrhotic patients: systematic review. World J Gastroenterol. 2014;20:5737.

    Article  Google Scholar 

  58. Harding DJ, Perera MT, Frederick C, Olliff S, Tripathi D. Portal vein thrombosis in cirrhosis: controversies and latest developments. World J Gastroenterol. 2015;21:6769–84.

    Article  Google Scholar 

  59. Shatzel J, Dulai PS, Harbin D, Cheung H, Reid TN, Kim J, et al. Safety and efficacy of pharmacological thromboprophylaxis for hospitalized patients with cirrhosis: a single-center retrospective cohort study. J Thromb Haemost. 2015;13:1245.

    Article  CAS  Google Scholar 

  60. Intagliata NM, Henry ZH, Shah N, Lisman T, Caldwell SH, Northup PG. Prophylactic anticoagulation for venous thromboembolism in hospitalized cirrhosis patients is not associated with high rates of gastrointestinal bleeding. Liver Int. 2013;34:26.

    Article  Google Scholar 

  61. Georgiou C, Inaba K, Teixeira PGR, Hadjizacharia P, Chan LS, Brown C, et al. Cirrhosis and trauma are a lethal combination. World J Surg. 2009;33:1087.

    Article  Google Scholar 

  62. Tapper EB, Halbert B, Mellinger J. Rates of and reasons for hospital readmissions in patients with cirrhosis: a multistate population-based cohort study. Clin Gastroenterol Hepatol. 2016;14:1181.

    Article  Google Scholar 

  63. Volk ML, Tocco RS, Bazick J, Rakoski MO, Lok AS. Hospital readmissions among patients with decompensated cirrhosis. Am J Gastroenterol. 2011;107:247.

    Article  Google Scholar 

  64. Tapper EB, Finkelstein D, Mittleman MA, Piatkowski G, Chang M, Lai M. A quality improvement initiative reduces 30-day rate of readmission for patients with cirrhosis. Clin Gastroenterol Hepatol. 2016;14:753.

    Article  Google Scholar 

  65. Tatum JM, Barmparas G, Ko A, Dhillon N, Smith E, Margulies DR, Ley EJ. Analysis of survival after initiation of continuous renal replacement therapy in a surgical intensive care unit. JAMA Surg. 2017. https://doi.org/10.1001/jamasurg.2017.1673. [Epub ahead of print] PubMed PMID: 28636702

  66. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60:646–9.

    Article  CAS  Google Scholar 

  67. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33(2):464–70.

    Article  CAS  Google Scholar 

  68. Biggins SW, Kim WR, Terrault NA, Saab S, Balan V, Schiano T, et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology. 2006;130(6):1652–60.

    Article  Google Scholar 

  69. United Network for Organ Sharing (UNOS). Calculators. Accessed 11 July 2017. https://www.transplantpro.org/news/technology/policy-and-system-changes-effective-january-11-2016-adding-serum-sodium-to-meld-calculation/

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA, USA

    James M. Tatum & Eric J. Ley

Authors
  1. James M. Tatum
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eric J. Ley
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to James M. Tatum .

Editor information

Editors and Affiliations

  1. Brigham and Womens’s Hospital, Harvard Medical School, Boston, Massachusetts, USA

    Ali Salim

  2. Dell Medical School, University of Texas at Austin, Austin, Texas, USA

    Carlos Brown

  3. Division of Trauma Surgery, Rm C5L100, University of Southern California, Los Angeles, California, USA

    Kenji Inaba

  4. Trauma and Emergency Surgery Service, Legacy Emanuel Medical Center, Portland, Oregon, USA

    Matthew J. Martin

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Tatum, J.M., Ley, E.J. (2018). Cirrhosis and End-Stage Liver Disease. In: Salim, A., Brown, C., Inaba, K., Martin, M. (eds) Surgical Critical Care Therapy . Springer, Cham. https://doi.org/10.1007/978-3-319-71712-8_51

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-71712-8_51

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-71711-1

  • Online ISBN: 978-3-319-71712-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation